as 05-08-2025 4:00pm EST
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Founded: | 2008 | Country: | Canada |
Employees: | N/A | City: | N/A |
Market Cap: | 103.3M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 77.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.07 | EPS Growth: | N/A |
52 Week Low/High: | $0.50 - $1.31 | Next Earning Date: | 06-26-2025 |
Revenue: | $44,936 | Revenue Growth: | 92.38% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ZTEK Breaking Stock News: Dive into ZTEK Ticker-Specific Updates for Smart Investing
ACCESS Newswire
10 days ago
ACCESS Newswire
16 days ago
Simply Wall St.
21 days ago
ACCESS Newswire
22 days ago
ACCESS Newswire
23 days ago
ACCESS Newswire
25 days ago
Newsfile
a month ago
ACCESS Newswire
2 months ago
The information presented on this page, "ZTEK Zentek Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.